Skip to main content
Premium Trial:

Request an Annual Quote

Celera Shares Fall as Earnings Miss Analyst Estimates

NEW YORK (GenomeWeb News) – Shares of Celera plummeted more than 20 percent today after the firm yesterday reported a loss for its fourth fiscal quarter and forecast lower revenue than analysts expected for 2009.

The company's shares were trading at $7.26 this afternoon, down 22 percent from yesterday's close of $9.34.

Celera yesterday reported revenues of $47.3 million for the three-month period ended Dec. 27, which was in line with analyst estimates.

However, the company's net loss of $6.1 million, or $.08 per share, for the quarter missed analysts' forecasts for a profit of $.01 per share.

The firm expects to bring in revenues of between $192 million and $202 million for fiscal-year 2009, as well as mid-single digit EPS on a non-GAAP basis for the year.

According to Thomson Reuters, analysts had expected a profit of $.19 per share for the year and $214.5 million in revenue.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.